Community Supervision Leadership Lab Training
ID: 356413Type: Posted
Overview

Buyer

National Institute of Corrections (USDOJ-BOP-NIC)

Award Range

$0 - $200K

Eligible Applicants

Others

Funding Category

Other

Funding Instrument

Cooperative Agreement

Opportunity Category

Other

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institute of Corrections is offering a Cooperative Agreement for the continuation of the Community Supervision Leadership Lab Training, aimed at enhancing leadership skills within community supervision settings. This opportunity is designed to deliver specialized training that supports the development of effective community supervision practices, which are crucial for improving outcomes in correctional settings. The total estimated funding for this program is $200,000, with a single award expected to be made, and interested parties should note that the application process is not open at this time. For further inquiries, contact Cameron D. Coblentz at ccoblentz@bop.gov or by phone at 202-514-0053, with a close date for this opportunity set for October 15, 2024.

    Point(s) of Contact
    Files
    No associated files provided.
    Similar Opportunities
    HEAL Initiative: JCOIN Phase II Innovation Hubs (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the HEAL Initiative: JCOIN Phase II Innovation Hubs (R01 Clinical Trial Optional) to support research on effective interventions for individuals with substance use disorders (SUDs) within the criminal-legal system. This initiative aims to enhance the delivery of medication for opioid use disorder (MOUD) and address the overdose crisis by establishing multiple research centers that will collaborate with resource centers to improve treatment access and continuity of care for justice-involved populations. With a total funding budget of $5 million, the NIH plans to award five to seven grants, each with a maximum direct cost of $2.25 million, for projects lasting up to five years. Interested applicants must submit their proposals by January 22, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    HEAL Initiative: JCOIN Phase II Community Engaged Research Resource Center (U24 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the HEAL Initiative for the JCOIN Phase II Community Engaged Research Resource Center (CERRC), aimed at addressing the overdose crisis among individuals involved in the criminal-legal system. This initiative seeks to engage various stakeholders in researching effective interventions for substance use disorders (SUD) and enhancing continuity of care between public health and public safety agencies, with a focus on community engagement and diversity, equity, and inclusion (DEI). The funding, capped at $750,000 per year, is available for projects that include engaging individuals with lived experience, creating public resources for community-engaged research, and conducting rapid turnaround research projects, with applications due by January 23, 2025. For further information, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity announcement at https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-026.html.
    Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial NOT Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), in collaboration with the Centers for Disease Control and Prevention (CDC), has announced the Innovation Corps (I-Corps) at NIH Program, aimed at enhancing the commercialization of biomedical innovations from Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Phase I projects. This program provides administrative supplement awards to eligible small business concerns, facilitating entrepreneurship training and assisting teams in refining their commercialization strategies through customer discovery activities over an eight-week course. With a total funding pool of up to $2.64 million available for up to 48 awards, individual grants are capped at $55,000, and applications must be submitted by January 31, 2025. Interested applicants are encouraged to contact NIH Grants Information at grantsinfo@nih.gov for further guidance before applying.
    NCI National Clinical Trials Network - Network Lead Academic Participating Sites (UG1 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the National Cancer Institute (NCI) for the establishment of Network Lead Academic Participating Sites (LAPS) within the National Clinical Trials Network (NCTN) to enhance cancer clinical trials for adult patients. This initiative aims to foster scientific leadership and collaboration among U.S. Network Groups, with a focus on robust trial accrual and outreach to underrepresented populations. The NCI plans to allocate up to $35.1 million to support 32 to 40 awards, with each award having a maximum budget of $1.7 million per year over a six-year project period. Interested applicants can find more information and application guidelines at the provided link, with proposals due by February 24, 2025. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    HEAL Initiative: JCOIN Phase II Economic Research Resource Center (U24 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is soliciting applications for the HEAL Initiative: JCOIN Phase II Economic Research Resource Center (U24 Clinical Trial Optional), aimed at addressing substance use disorder (SUD) within the criminal-legal system. This initiative focuses on enhancing research and effective interventions for individuals at risk of overdose during their transition through various stages of the justice system, with an emphasis on increasing access to medication for opioid use disorder (MOUD). The program will support multi-site studies, conduct cost analyses, and develop resources for practitioners, with a total funding amount of $800,000 allocated for one award. Interested applicants must submit their proposals by January 22, 2025, and can direct inquiries to grantsinfo@nih.gov for further information.
    Notice of Intent to Publish a Funding Opportunity Announcement for NCI National Clinical Trials Network - Network Lead Academic Participating Sites (UG1 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a funding opportunity announcement for the NCI National Clinical Trials Network, specifically targeting Network Lead Academic Participating Sites through a cooperative agreement. The primary objective is to provide scientific leadership in developing and conducting multi-center clinical trials for various cancer treatments, contributing to substantial patient accrual across the NCTN. This initiative is crucial for advancing clinical research and improving treatment options for diverse patient populations affected by cancer. The estimated total program funding is $35,100,000, with an award ceiling of $1,700,000 and approximately 35 awards expected. Interested applicants should prepare for the anticipated application due date in late February 2025, following the NOFO publication in Fall 2024.
    OJJDP FY25 Enhancing Youth Defense Training and Technical Assistance
    Active
    Office of Juvenile Justice Delinquency Prevention
    The Office of Juvenile Justice Delinquency Prevention (OJJDP) is offering a federal grant opportunity titled "OJJDP FY25 Enhancing Youth Defense Training and Technical Assistance." This initiative aims to enhance the quality of legal representation and expand the services available to justice-involved youth by providing specialized training, tools, resources, and intensive technical assistance to defense practitioners. The funding, which amounts to a total of $900,000 with a ceiling of $900,000 for a single award, is crucial for improving legal services in the juvenile justice system. Interested applicants, specifically small businesses, must submit their proposals by February 4, 2025, and can reach out to grants@ncjrs.gov for further inquiries. For more details, please visit the full announcement at OJJDP Funding Announcement.
    OJJDP FY25 Second Chance Act Addressing the Needs of Incarcerated Parents and Their Minor Children
    Active
    Office of Juvenile Justice Delinquency Prevention
    The Office of Juvenile Justice Delinquency Prevention (OJJDP) is offering a federal grant titled "OJJDP FY25 Second Chance Act Addressing the Needs of Incarcerated Parents and Their Minor Children." This funding opportunity aims to support states, local governments, Tribal communities, and community-based organizations in developing or expanding programs within detention or correctional facilities that address the needs of incarcerated parents with children under 18, focusing on preventing violent crime and reducing recidivism. The grant is particularly significant as it seeks to provide essential support for minor children affected by parental incarceration, thereby fostering healthier family dynamics and community safety. Interested applicants can apply for funding ranging from $0 to $750,000, with an estimated total program funding of $4 million available for approximately five awards. The application deadline is February 6, 2025, and inquiries can be directed to grants@ncjrs.gov for further information.
    Projects of National Significance: Empowering Individuals
    Active
    Administration for Community Living
    The Administration for Community Living is forecasting a funding opportunity titled "Projects of National Significance: Empowering Individuals," aimed at enhancing the lives of individuals with intellectual and developmental disabilities (ID/DD) and their families. This initiative, supported by the Developmental Disabilities Assistance and Bill of Rights Act, seeks to empower these individuals through policy advocacy, leadership development, and increased knowledge of available supports, ultimately fostering their full participation in community life. The program anticipates awarding five cooperative agreements, with funding amounts ranging from $300,000 to $375,000, totaling an estimated $1,875,000, and interested applicants must be private institutions of higher education or eligible faith-based and community organizations. For further details, applicants can contact Larissa Crossen at (202) 795-7333 or via email at larissa.crossen@acl.hhs.gov, with proposals expected to be submitted between March 31, 2024, and May 30, 2024, and awards anticipated by September 1, 2024.
    Notice of Intent to Publish a Funding Opportunity Announcement for NCI National Clinical Trials Network - Network Group Integrated Translational Science Centers (UG1 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is forecasting a funding opportunity for the NCI National Clinical Trials Network - Network Group Integrated Translational Science Centers, designated as a UG1 Clinical Trial Not Allowed cooperative agreement. This initiative aims to support leadership and expertise in integrating translational science into clinical trials, particularly focusing on multi-center, late-phase treatment trials across various cancer types and patient demographics. The total estimated program funding is $2 million, with an award ceiling of $850,000 and an expected two awards to be made. The Notice of Funding Opportunity (NOFO) is anticipated to be published in Fall 2024, with applications due in late February 2025, and awards expected to be announced by March 1, 2026. Interested applicants should prepare their proposals accordingly.